India and Japan signed a Memorandum for a collaboration in biotech area

| |
0
123

India and Japan today signed a Memorandum of Understanding (MoU) for expansion of an international laboratory set up for a collaborative research in the area of biotechnology.

The pact, signed on a day Japanese Prime Minister Shinzo Abe arrived in India on a two-day visit, envisages the expansion of the laboratory set up by India’s Department of Biotechnology (DBT) and Japan’s National Institute of Advanced Science and Technology under the name of DAILAB.

The Memorandum of Understanding is likely to be exchanged after the delegation-level talks between Abe and Prime Minister Narendra Modi.

DAILAB is located in Japan. The new centre to come up after the pact will be called DAICENTER. It will seek to enhance the level of joint research, training and networking programmes that had been underway through DAILAB and its six ancillary institutes called Satellite International Institutes for Special Training, Education and Research (SISTERS) for the past three years.

It would also focus on connecting the academia to the industry and network innovation to entrepreneurship promoting science and technology relationships of the two countries.

SOURCE: indiainfoline
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.
Isaltis Banner